Quanterix Corporation Foreign Currency Transaction Loss, before Tax
Quanterix Corporation (QTRX) reported Foreign Currency Transaction Loss, before Tax of $359.00 thousand for the 9-month period ending 2023-09-30, per its 10-K/A filed 2024-12-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2024-12-26
- Quanterix Corporation foreign currency transaction loss, before tax for the quarter ending 2023-09-30 was $154.00K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 9 month |
|---|---|---|---|
| 2023-09-30 | $154.00K derived: 10-K/A 9 month − 10-Q 6 month · filed 2024-12-26 | $359.00K 10-K/A · filed 2024-12-26 | |
| 2023-06-30 | $205.00K 10-Q · filed 2023-08-08 | ||
| 2022-09-30 | $167.00K 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |